Detalles de la búsqueda
1.
Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancer.
Breast Cancer Res Treat
; 169(2): 333-340, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29396664
2.
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Oncoimmunology
; 13(1): 2290787, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38170160
Resultados
1 -
2
de 2
1
Próxima >
>>